Xeris Pharmaceuticals, Inc. · 6 hours ago
Accounting Intern
Xeris Pharmaceuticals, Inc. is a growth-oriented biopharmaceutical company committed to improving patient lives through innovative products. The Accounting Intern will focus on supporting accounting processes, updating financial reports, and collaborating with finance teams to analyze performance and manage expenses.
BiotechnologyDiabetesHealth CarePharmaceuticalTherapeutics
Responsibilities
Partner with Accounting team and Accounts Payable team to support in weekly or monthly tasks following controls and standard operating procedures
Update and create financial reporting focusing on automated processes for continued use
Analyze month-end results and summarize values and explanations for significant variances compared to historical actuals and forecast expectations
Contribute to monthly reporting package updates provided to department leadership
Partner with finance to help analyze commercial functions’ spend and manage expenses to Budget
Support financial forecast and prioritization processes
Ad-hoc accounting and finance projects
At the conclusion of the internship, prepare a comprehensive review of the internship experience and present to the organization
Qualification
Required
Pursuing a degree in Accounting, Finance, or related field
Minimum GPA 3.0
Returning to academic program at a credentialed institution for at least one semester post-internship
Proficiency in Microsoft Office with a focus on Excel
Ability to make logical and sound decisions and to know when to act independently and when to seek assistance
Competencies : Analytical skills, Teamwork & Collaboration, Attention to Detail, Self-Starter, Problem Solving, Organizational skills, Adaptability, Professionalism, Written and Verbal Communications, Presentation skills, Critical Thinking
Position may require periodic evening and weekend work, as necessary, to fulfill obligations
This role is based in Xeris' Chicago office and requires five days per week in the office
Company
Xeris Pharmaceuticals, Inc.
We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.
Funding
Current Stage
Public CompanyTotal Funding
$548.5MKey Investors
Hayfin Capital ManagementArmistice CapitalDeerfield
2024-03-06Post Ipo Debt· $200M
2022-01-03Post Ipo Equity· $30M
2021-03-11Post Ipo Equity· $27M
Leadership Team
Recent News
2026-01-09
The Motley Fool
2026-01-03
Company data provided by crunchbase